Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Viela Bio, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Viela Bio, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Viela Bio, Inc.Listing unverified | Buy | $8.1M | conv 42Cluster | SEC | |
PhaseBio Pharmaceuticals IncListing unverified | SellD (derivative) | $13.7K | SEC | ||
PhaseBio Pharmaceuticals IncListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PhaseBio Pharmaceuticals IncListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PhaseBio Pharmaceuticals IncListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PhaseBio Pharmaceuticals IncListing unverified | OtherD (derivative) | $13.7K | SEC | ||
PhaseBio Pharmaceuticals IncListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
PhaseBio Pharmaceuticals IncListing unverified | Buy | $3M | conv 44Cluster | SEC | |
Entasis Therapeutics Holdings Inc.Listing unverified | Buy | $3.7M | conv 47ClusterFirst in 12mo | SEC | |
Entasis Therapeutics Holdings Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Entasis Therapeutics Holdings Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |